200,000+ products from a single source!

sales@angenechem.com

Home > Sulfanilamide > 121-61-9

121-61-9

121-61-9 | 4-Acetamidobenzenesulfonamide

CAS No: 121-61-9 Catalog No: AG003KM8 MDL No:MFCD00035784

Product Description

Catalog Number:
AG003KM8
Chemical Name:
4-Acetamidobenzenesulfonamide
CAS Number:
121-61-9
Molecular Formula:
C8H10N2O3S
Molecular Weight:
214.2416
MDL Number:
MFCD00035784
IUPAC Name:
N-(4-sulfamoylphenyl)acetamide
InChI:
InChI=1S/C8H10N2O3S/c1-6(11)10-7-2-4-8(5-3-7)14(9,12)13/h2-5H,1H3,(H,10,11)(H2,9,12,13)
InChI Key:
PKOFBDHYTMYVGJ-UHFFFAOYSA-N
SMILES:
CC(=O)Nc1ccc(cc1)S(=O)(=O)N
EC Number:
204-486-7
UNII:
340484WZ3L

Properties

Complexity:
299  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
214.041g/mol
Formal Charge:
0
Heavy Atom Count:
14  
Hydrogen Bond Acceptor Count:
4  
Hydrogen Bond Donor Count:
2  
Isotope Atom Count:
0
Molecular Weight:
214.239g/mol
Monoisotopic Mass:
214.041g/mol
Rotatable Bond Count:
2  
Topological Polar Surface Area:
97.6A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
0

Literature

Title Journal
N-(4-Sulfamoylphen-yl)acetamide. Acta crystallographica. Section E, Structure reports online 20120401
Comparison of the efficacy of topical N-acetyl-cysteine and a topical steroid-antibiotic combination therapy in the treatment of meibomian gland dysfunction. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20120201
Endogenous endophthalmitis with an unusual infective agent: Actinomyces neuii. European journal of ophthalmology 20120101
Treatment of rosacea. Annales de dermatologie et de venereologie 20111101
Demodex folliculitis. Journal of pediatric and adolescent gynecology 20111001
[Treatment of rosacea]. Annales de dermatologie et de venereologie 20110901
Genetic variability of enterobacterial resistant integrons. Bulletin of experimental biology and medicine 20110901
Effectiveness and safety of doxycycline 40 mg (30-mg immediate-release and 10-mg delayed-release beads) once daily as add-on therapy to existing topical regimens for the treatment of papulopustular rosacea: results from a community-based trial. Cutis 20101101
[Rosacea: pathogenesis, clinical forms and therapy]. Orvosi hetilap 20100725
Pharmacokinetic study on the mechanism of interaction of sulfacetamide sodium with bovine serum albumin: a spectroscopic method. Biopharmaceutics & drug disposition 20100301
The multifunctionality of 10% sodium sulfacetamide, 5% sulfur emollient foam in the treatment of inflammatory facial dermatoses. Journal of drugs in dermatology : JDD 20100301
Sulfacetamide loaded Eudragit® RL100 nanosuspension with potential for ocular delivery. Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques 20100101
Interaction of topical sulfacetamide and topical dapsone with benzoyl peroxide. Archives of dermatology 20090901
Updates on the pathophysiology and management of acne rosacea. Postgraduate medicine 20090901
Bioadhesive sulfacetamide sodium microspheres: evaluation of their effectiveness in the treatment of bacterial keratitis caused by Staphylococcus aureus and Pseudomonas aeruginosa in a rabbit model. European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 20090801
Treatment of papulopustular rosacea with sodium sulfacetamide 10%/sulfur 5% emollient foam. Journal of drugs in dermatology : JDD 20090301
Rosacea and its topical management. Skin therapy letter 20090201
Lack of aquaporin-4 water transport inhibition by antiepileptics and arylsulfonamides. Bioorganic & medicinal chemistry 20080801
Optimal conditions for determination of zinc bacitracin, polymyxin B, oxytetracycline and sulfacetamide in animal feed by micellar electrokinetic capillary chromatography. Food additives & contaminants. Part A, Chemistry, analysis, control, exposure & risk assessment 20080401
Pilot investigation of the hydrating effects of topical acne medications. Journal of drugs in dermatology : JDD 20070801
Identification of arylsulfonamides as Aquaporin 4 inhibitors. Bioorganic & medicinal chemistry letters 20070301
[Determination of 12 sulfonamides in cosmetics by ultra performance liquid chromatography]. Se pu = Chinese journal of chromatography 20070301
Copper complexes with heterocyclic sulfonamides: synthesis, spectroscopic characterization, microbiological and SOD-like activities: crystal structure of [Cu(sulfisoxazole)2(H2O)4] . 2H2O. Journal of inorganic biochemistry 20060701
Epidermal growth factor receptor (EGFR) inhibitor associated skin eruption. Journal of drugs in dermatology : JDD 20060401
Topical therapies for rosacea. Journal of drugs in dermatology : JDD 20060101
Researches concerning the synthesis and antituberculosis action of some new sulphacetamide derivatives. Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi 20060101
Carbonic anhydrase inhibitors: inhibition of the tumor-associated isozymes IX and XII with a library of aromatic and heteroaromatic sulfonamides. Bioorganic & medicinal chemistry letters 20051101
Demodex mites as a cause of human disease. Cutis 20051101
Resistant scalp folliculitis secondary to Demodex infestation. Cutis 20051101
Combination sodium sulfacetamide 10% and sulfur 5% cream with sunscreens versus metronidazole 0.75% cream for rosacea. Cutis 20050601
Diagnosing and managing the patient with rosacea. Cutis 20050401
Seborrheic dermatitis. The link between facial rash and neurologic disease. Postgraduate medicine 20050301
Adjunctive skin care in the management of rosacea: cleansers, moisturizers, and photoprotectants. Cutis 20050301
Topical metronidazole combination therapy in the clinical management of rosacea. Journal of drugs in dermatology : JDD 20050101
Refractory Demodex folliculitis in five children with acute lymphoblastic leukemia. Pediatric dermatology 20050101
Rosacea. An overview of diagnosis and management. Advance for nurse practitioners 20041201
Investigation of radiosterilization and dosimetric features of sulfacetamide sodium. Journal of pharmaceutical and biomedical analysis 20041119
Actinomyces canaliculitis: diagnosis of a masquerading disease. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 20040801
A double-blind comparative study of sodium sulfacetamide lotion 10% versus selenium sulfide lotion 2.5% in the treatment of pityriasis (tinea) versicolor. Cutis 20040601
Facial hygiene and comprehensive management of rosacea. Cutis 20040301
Carbonic anhydrase inhibitors. Inhibition of mitochondrial isozyme V with aromatic and heterocyclic sulfonamides. Journal of medicinal chemistry 20040226
Medical treatment of rosacea with emphasis on topical therapies. Expert opinion on pharmacotherapy 20040101
Evaluating the role of topical therapies in the management of rosacea: focus on combination sodium sulfacetamide and sulfur formulations. Cutis 20040101
The treatment of rosacea. Cutis 20040101
Rosac Cream With Sunscreens (sodium sulfacetamide 10% and sulfur 5%). Skinmed 20040101
Sulfur/sodium sulfacetamide preparations. Skinmed 20040101
Nocardia keratitis in a human immunodeficiency virus patient. Japanese journal of ophthalmology 20040101
The use of sulfur in dermatology. Journal of drugs in dermatology : JDD 20040101
Determination of prednisolone acetate, sulfacetamide and phenylefrine in local pharmaceutical preparations by micellar electrokinetic chromatography. Journal of pharmaceutical and biomedical analysis 20030401
New drugs and dosage forms. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20030301
A status report on the medical management of rosacea: focus on topical therapies. Cutis 20021101
Route of antibiotic administration for conjunctivitis. The Pediatric infectious disease journal 20021001
Studies on the influence of auxiliary substances on the physico-chemical characteristics of ophthalmic drugs. Part I. Studies on the influence of auxiliary substances on the critical micellar concentration of surfactants solutions in eye drops containing sulphacetamidum natricum. Acta poloniae pharmaceutica 20020101
Spectrophotometric determination of sulphacetamide. Bollettino chimico farmaceutico 20020101
Topical bactrim versus trimethoprim and sulfonamide against nocardia keratitis. Cornea 20010301
Ocular nocardia infections with special emphasis on the cornea. Survey of ophthalmology 20010101
A novel kind of antitumour drugs using sulfonamide as parent compound. European journal of medicinal chemistry 20010101
Design and synthesis of benzoic acid derivatives as influenza neuraminidase inhibitors using structure-based drug design. Journal of medicinal chemistry 19971205
[The effective antibacterial spectrum of sulfacetamide]. Klinische Monatsblatter fur Augenheilkunde 19920301
Change in the kinetics of sulphacetamide tissue distribution in Walker tumor-bearing rats. Drug metabolism and disposition: the biological fate of chemicals 19750101

© 2019 Angene International Limited. All rights Reserved.